Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Grid2ip Activators

CSMD3 (CUB and Sushi Multiple Domains 3) is a gene that encodes a protein belonging to the CSMD family. This family is characterized by proteins with multiple domains, including CUB (complement C1r/C1s, Uegf, Bmp1) and Sushi (or complement control protein, CCP) domains. The CSMD3 protein is notable for its large size and extensive domain architecture, making it a significant molecule in cell signaling and immune response.The CSMD3 protein is primarily expressed in epithelial tissues and has been implicated in the development and maintenance of these tissues. Its structure, featuring numerous CUB and Sushi domains, suggests a role in cell adhesion and signaling processes. These domains are typically involved in protein-protein interactions and are essential in various biological functions, including complement regulation, embryonic development, and immune responses.

Emerging research has highlighted the role of CSMD3 in various pathological conditions. Notably, alterations in the CSMD3 gene have been associated with certain types of cancer, particularly in epithelial-origin cancers. This association suggests that CSMD3 may play a role in tumorigenesis, possibly through its involvement in cell adhesion and signaling pathways that are crucial in cancer development and progression. Furthermore, CSMD3 has been studied in the context of neurological disorders. Variations in the CSMD3 gene have been linked to neurodevelopmental disorders, indicating its role in brain development and function.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

N-Methyl-D-Aspartic acid (NMDA)

6384-92-5sc-200458
sc-200458A
50 mg
250 mg
$109.00
$369.00
2
(1)

An agonist for NMDA receptors, potentially influencing synaptic plasticity and neuronal signaling pathways related to GRID2IP.

D-Cycloserine

68-41-7sc-221470
sc-221470A
sc-221470B
sc-221470C
200 mg
1 g
5 g
25 g
$28.00
$77.00
$142.00
$530.00
4
(0)

A partial agonist at the glycine site of NMDA receptors, potentially modulating neuronal signaling.

(±)-Baclofen

1134-47-0sc-200464
sc-200464A
1 g
5 g
$56.00
$258.00
(1)

A GABA receptor agonist, potentially modulating neuronal activity and influencing pathways associated with GRID2IP.

Nimodipine

66085-59-4sc-201464
sc-201464A
100 mg
1 g
$61.00
$307.00
2
(1)

A calcium channel blocker, which can modulate neuronal signaling and potentially impact GRID2IP-associated pathways.

Gabapentin

60142-96-3sc-201481
sc-201481A
sc-201481B
20 mg
100 mg
1 g
$53.00
$94.00
$135.00
7
(1)

Modulates GABAergic signaling and may influence neuronal pathways related to GRID2IP.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Used in neurological research and therapy, potentially affecting neuronal signaling pathways.

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

A broad-spectrum anticonvulsant, possibly influencing various neuronal pathways.

Memantine hydrochloride

41100-52-1sc-203628
50 mg
$69.00
4
(2)

An NMDA receptor antagonist, used in neurological disorders, potentially affecting neuronal pathways associated with GRID2IP.